Print Page  Close Window

2010 ASX Announcements  Receive Email Alerts |  RSS Feeds Keyword Search   2010 | 2009 | 2008 | 2007 | 2006 Date Title   09/06/10 Option Exercise - ASX Appendix 3B 09/06/10 FDA Grants HeartWare Second Patient Allotment Under CAP 08/19/10 Option Grant - ASX Appendix 3B 08/19/10 Option Exercise - ASX Appendix 3B 08/12/10 HeartWare Study to be Late-Breaker at American Heart Assn. 08/09/10 Appendix 4D and Half Year Financial Statements (US GAAP) 08/06/10 HeartWare Announces Second Quarter Results 08/05/10 HeartWare to Present at Canaccord Growth Conference 07/30/10 HeartWare to Present at Wedbush Best Ideas Conference 07/28/10 Second Quarter Earnings Release Call 07/07/10 Amended ASX Appendix 3Bs 07/02/10 Option Exercise - ASX Appendix 3B 07/02/10 Option Grant - ASX Appendix 3B 06/25/10 Announces Board Succession 06/18/10 HeartWare to present at Wells Fargo 06/18/10 Exercise of Options - ASX Appendix 3B 06/15/10 HeartWare To Commence Destination Therapy Trial 06/07/10 Exercise and Cancellation of Options 05/07/10 Change of Director`s Interest Notices 05/05/10 Annual General Meeting Results 05/05/10 Grant of Incentive Equity - Appendix 3B 05/05/10 Annual General Meeting Materials 05/05/10 Appendix 3B 05/05/10 First Quarter 2010 Financial Statements 05/04/10 First Quarter Results 05/03/10 Appendix 3B 04/27/10 Initiates voluntary repairs and recalls certain controllers 04/27/10 First 100 Patient Commercial and Clinical Data 04/12/10 Heartware to Report Financial Results First Quarter of 2010 04/12/10 Notice of Annual General Meeting 04/08/10 FDA Approves Continued Access Protocol for BTT 03/26/10 Amended ASX Appendix 3B 03/24/10 Change of Director`s Interest Notice 03/24/10 Appendix 3B - Exercise of Stock Options 03/05/10 HeartWare to Present at Annual Roth Growth Conference 03/03/10 Grant and Cancellation of Equity - ASX Appendix 3B 03/03/10 Change of Director's Interest Notice 03/03/10 Appendix 3B - Vesting of Preformance Rights 02/24/10 Annual Report for 2009 and ASX Appendix 4E 02/23/10 Reports Q4 Rev. of US$12.2M and Annual Rev. of US$24.2M 02/23/10 Enrollment of US Bridge to Transplant Trial Completed 02/09/10 Fourth Quarter and Annual Results for 2009 Earnings Call 02/03/10 Completion of US$62 million Capital Raising 02/03/10 Capital Raising - Cleansing Notice 02/03/10 Capital Raising - ASX Appendix 3B Allotment 02/01/10 Exercise and Cancellation of Options 01/28/10 Pricing of Public Offering of Common Stock 01/27/10 Prospectus for Public Offering of HeartWare Common Stock 01/27/10 Public Offering of HeartWare Common Stock 01/12/10 Shareholder Update 01/04/10 Thoratec Loan Facility Update